UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The consensus sleep diary: standardizing prospective sleep self-monitoring

Sleep (New York, N.Y.), 2012-02, Vol.35 (2), p.287-302

2012

Volltextzugriff (PDF)

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

Lancet neurology, 2014-05, Vol.13 (5), p.461-471

2014

Volltextzugriff (PDF)

Obstructive Sleep Apnea and Incidence of Postoperative Delirium after Elective Knee Replacement in the Nondemented Elderly

Anesthesiology (Philadelphia), 2012-04, Vol.116 (4), p.788-796

2012

Volltextzugriff (PDF)

Sleep EEG Predictors and Correlates of the Response to Cognitive Behavioral Therapy for Insomnia

Sleep (New York, N.Y.), 2010-05, Vol.33 (5), p.669-677

2010

Volltextzugriff (PDF)

A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder

The journal of clinical psychiatry, 2007-02, Vol.68 (2), p.254-260

2007

Volltextzugriff (PDF)

The sleep effects of lurasidone: a placebo-controlled cross-over study using a 4-h phase-advance model of transient insomnia

Human psychopharmacology, 2016-05, Vol.31 (3), p.206-216

2016

Volltextzugriff (PDF)

Loop diuretics have anxiolytic effects in rat models of conditioned anxiety

PloS one, 2012-04, Vol.7 (4), p.e35417

2012

Volltextzugriff (PDF)

Insomnia Patients With Objective Short Sleep Duration Have a Blunted Response to Cognitive Behavioral Therapy for Insomnia

Sleep (New York, N.Y.), 2017-01, Vol.40 (1)

2017

Volltextzugriff (PDF)

Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data

Psychopharmacology, 2017-06, Vol.234 (11), p.1703-1711

2017

Volltextzugriff (PDF)

Objective but Not Subjective Short Sleep Duration Associated with Increased Risk for Hypertension in Individuals with Insomnia

Sleep (New York, N.Y.), 2016-05, Vol.39 (5), p.1037-1045

2016

Volltextzugriff (PDF)

Cognitive Behavioral Insomnia Therapy for Those With Insomnia and Depression: A Randomized Controlled Clinical Trial

Sleep (New York, N.Y.), 2017-04, Vol.40 (4)

2017

Volltextzugriff (PDF)

Reducing Suicidal Ideation Through Insomnia Treatment (REST-IT): A Randomized Clinical Trial

The American journal of psychiatry, 2019-11, Vol.176 (11), p.957-965

2019

Volltextzugriff (PDF)

A randomized proof-of-mechanism trial applying the ‘fast-fail’ approach to evaluating κ-opioid antagonism as a treatment for anhedonia

Nature medicine, 2020-05, Vol.26 (5), p.760-768

2020

Volltextzugriff (PDF)

Effectiveness of Sequential Psychological and Medication Therapies for Insomnia Disorder: A Randomized Clinical Trial

JAMA psychiatry (Chicago, Ill.), 2020-11, Vol.77 (11), p.1107

2020

Volltextzugriff (PDF)

Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials

Biological psychiatry (1969), 2016-01, Vol.79 (2), p.136-148

2016

Volltextzugriff (PDF)

Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications

Journal of sleep research, 2019-04, Vol.28 (2), p.e12782-n/a

2019

Volltextzugriff (PDF)

The relationship of person-specific eveningness chronotype, greater seasonality, and less rhythmicity to suicidal behavior: A literature review

Journal of affective disorders, 2018-02, Vol.227, p.721-730

2018

Volltextzugriff (PDF)

Long-Term Trazodone Use and Cognition: A Potential Therapeutic Role for Slow-Wave Sleep Enhancers

Journal of Alzheimer's disease, 2019-01, Vol.67 (3), p.911-921

2019

Volltextzugriff (PDF)

Optimizing computation of overnight decline in delta power: Evidence for slower rate of decline in delta power in insomnia patients

Clinical neurophysiology, 2021-02, Vol.132 (2), p.545-553, Article 545

2021

Volltextzugriff (PDF)

Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia

Sleep (New York, N.Y.), 2010-11, Vol.33 (11), p.1553-1561

2010

Volltextzugriff (PDF)

International randomized-controlled trial of transcranial Direct Current Stimulation in depression

Brain stimulation, 2018-01, Vol.11 (1), p.125-133

2018

Volltextzugriff (PDF)

Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study

Sleep (New York, N.Y.), 2008-01, Vol.31 (1), p.79-90

2008

Volltextzugriff (PDF)

Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia

Sleep (New York, N.Y.), 2011-10, Vol.34 (10), p.1433-1442

2011

Volltextzugriff (PDF)

Comparison of diary-derived bladder and sleep measurements across OAB individuals, primary insomniacs, and healthy controls

International Urogynecology Journal, 2013-03, Vol.24 (3), p.501-508

2013

Volltextzugriff (PDF)

Restricting Benzodiazepines to Short-Term Prescription

JAMA psychiatry (Chicago, Ill.), 2015-07, Vol.72 (7), p.734

2015

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieArchives Of General Psychiatry

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(98)

Sprache

Englisch
(98)

Erscheinungsjahr

n.n

Thema

Humans
(95)
Female
(92)
Science & Technology
(91)
Life Sciences & Biomedicine
(90)
Middle Aged
(72)
Adult
(66)
Neurosciences & Neurology
(50)
Aged
(44)
Clinical Neurology
(41)
Neurosciences
(39)
Psychiatry
(38)
Treatment Outcome
(36)
Insomnia
(34)
Biological And Medical Sciences
(32)
Medical Sciences
(31)
Double-Blind Method
(29)
Psychology. Psychoanalysis. Psychiatry
(26)
Sleep Initiation And Maintenance Disorders - Drug Therapy
(25)
Sleep
(24)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The consensus sleep diary: standardizing prospective sleep self-monitoring

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

Obstructive Sleep Apnea and Incidence of Postoperative Delirium after Elective Knee Replacement in the Nondemented Elderly

Sleep EEG Predictors and Correlates of the Response to Cognitive Behavioral Therapy for Insomnia

A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder

The sleep effects of lurasidone: a placebo-controlled cross-over study using a 4-h phase-advance model of transient insomnia

Loop diuretics have anxiolytic effects in rat models of conditioned anxiety

Insomnia Patients With Objective Short Sleep Duration Have a Blunted Response to Cognitive Behavioral Therapy for Insomnia

Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data

Objective but Not Subjective Short Sleep Duration Associated with Increased Risk for Hypertension in Individuals with Insomnia

Cognitive Behavioral Insomnia Therapy for Those With Insomnia and Depression: A Randomized Controlled Clinical Trial

Reducing Suicidal Ideation Through Insomnia Treatment (REST-IT): A Randomized Clinical Trial

A randomized proof-of-mechanism trial applying the ‘fast-fail’ approach to evaluating κ-opioid antagonism as a treatment for anhedonia

Effectiveness of Sequential Psychological and Medication Therapies for Insomnia Disorder: A Randomized Clinical Trial

Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials

Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications

The relationship of person-specific eveningness chronotype, greater seasonality, and less rhythmicity to suicidal behavior: A literature review

Long-Term Trazodone Use and Cognition: A Potential Therapeutic Role for Slow-Wave Sleep Enhancers

Optimizing computation of overnight decline in delta power: Evidence for slower rate of decline in delta power in insomnia patients

Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia

International randomized-controlled trial of transcranial Direct Current Stimulation in depression

Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study

Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia

Comparison of diary-derived bladder and sleep measurements across OAB individuals, primary insomniacs, and healthy controls

Restricting Benzodiazepines to Short-Term Prescription

Aktive Filter

Suchergebnisse filtern